Fluicell Ab Stock Revenue
| FLUI Stock | SEK 0.05 0 6.17% |
Fluicell AB fundamentals help investors to digest information that contributes to Fluicell's financial success or failures. It also enables traders to predict the movement of Fluicell Stock. The fundamental analysis module provides a way to measure Fluicell's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Fluicell stock.
Fluicell |
Fluicell AB Company Revenue Analysis
Fluicell's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current Fluicell Revenue | 2.6 M |
Most of Fluicell's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Fluicell AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
| Competition |
Based on the latest financial disclosure, Fluicell AB reported 2.6 M of revenue. This is 99.97% lower than that of the Healthcare sector and 99.65% lower than that of the Biotechnology industry. The revenue for all Sweden stocks is 99.97% higher than that of the company.
Fluicell AB is rated # 2 in revenue category among its peers. Market size based on revenue of Biotechnology industry is currently estimated at about 25.75 Million. Fluicell retains roughly 2.6 Million in revenue claiming about 10% of stocks in Biotechnology industry.Fluicell Fundamentals
| Return On Equity | -1.13 | |||
| Return On Asset | -0.49 | |||
| Operating Margin | (8.62) % | |||
| Current Valuation | 49.13 M | |||
| Shares Outstanding | 24.49 M | |||
| Shares Owned By Insiders | 11.20 % | |||
| Shares Owned By Institutions | 0.67 % | |||
| Price To Book | 4.86 X | |||
| Price To Sales | 10.51 X | |||
| Revenue | 2.6 M | |||
| Gross Profit | 1.89 M | |||
| EBITDA | (21.08 M) | |||
| Net Income | (21.69 M) | |||
| Cash And Equivalents | 20.69 M | |||
| Cash Per Share | 1.45 X | |||
| Debt To Equity | 0.19 % | |||
| Current Ratio | 2.30 X | |||
| Book Value Per Share | 0.76 X | |||
| Cash Flow From Operations | (18.64 M) | |||
| Earnings Per Share | (1.68) X | |||
| Number Of Employees | 19 | |||
| Beta | 1.96 | |||
| Market Capitalization | 73.64 M | |||
| Total Asset | 26.98 M | |||
| Net Asset | 26.98 M |
About Fluicell Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Fluicell AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Fluicell using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Fluicell AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Fluicell Stock Analysis
When running Fluicell's price analysis, check to measure Fluicell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fluicell is operating at the current time. Most of Fluicell's value examination focuses on studying past and present price action to predict the probability of Fluicell's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fluicell's price. Additionally, you may evaluate how the addition of Fluicell to your portfolios can decrease your overall portfolio volatility.